GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » Price-to-Owner-Earnings

Syngene International (NSE:SYNGENE) Price-to-Owner-Earnings : 29.97 (As of May. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Price-to-Owner-Earnings?

As of today (2024-05-22), Syngene International's share price is ₹694.45. Syngene International's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹23.17. It's Price-to-Owner-Earnings for today is 29.97.


The historical rank and industry rank for Syngene International's Price-to-Owner-Earnings or its related term are showing as below:

NSE:SYNGENE' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.78   Med: 30.39   Max: 66.9
Current: 29.81

During the past 13 years, the highest Price-to-Owner-Earnings of Syngene International was 66.90. The lowest was 18.78. And the median was 30.39.


NSE:SYNGENE's Price-to-Owner-Earnings is ranked better than
53.7% of 162 companies
in the Biotechnology industry
Industry Median: 33.52 vs NSE:SYNGENE: 29.81

As of today (2024-05-22), Syngene International's share price is ₹694.45. Syngene International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹12.69. Therefore, Syngene International's PE Ratio for today is 54.72.

As of today (2024-05-22), Syngene International's share price is ₹694.45. Syngene International's EPS without NRI for the trailing twelve months (TTM) ended in was ₹12.91. Therefore, Syngene International's PE Ratio without NRI for today is 53.81.

During the past 13 years, Syngene International's highest PE Ratio without NRI was 69.89. The lowest was 27.56. And the median was 40.35.


Syngene International Price-to-Owner-Earnings Historical Data

The historical data trend for Syngene International's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Price-to-Owner-Earnings Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.04 42.32 61.61 36.38 30.28

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.38 - - - 30.28

Competitive Comparison of Syngene International's Price-to-Owner-Earnings

For the Biotechnology subindustry, Syngene International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Syngene International's Price-to-Owner-Earnings falls into.



Syngene International Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Syngene International's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=694.45/23.17
=29.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (NSE:SYNGENE) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Syngene International Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Syngene International's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines